These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 744231)

  • 21. [The effect of vincamine on cerebral blood flow as a function of application rate (author's transl)].
    Heiss WD; Podreka I; Samec P
    Arzneimittelforschung; 1977; 27(6a):1291-3. PubMed ID: 578455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiac toxicity of vincamine: a seven cases report of ventricular arrhythmias by parenteral administration of vincamine (author's transl)].
    Dany F; Merle L; Goudoud JC; Liozon F; Blanc P; Bouvot JC; Nicot G; Dangoumau J
    Therapie; 1981; 36(1):55-64. PubMed ID: 7233373
    [No Abstract]   [Full Text] [Related]  

  • 23. [Action of coffee on the cardiovascular system].
    Lentini S
    Minerva Med; 1971 Aug; 62(64):3021-5. PubMed ID: 5566885
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative pharmacodynamic properties of apolar alkaloids of Vinca minor L. (Apocynaceae) (vincamine, vinca fraction and vinacamine free vinca fraction)].
    Quevauviller A; Foussard-Blandpin O; Le Men J; Thomann-Dumont G
    Sem Hop Ther; 1977 Mar; 53(3):145-51. PubMed ID: 877588
    [No Abstract]   [Full Text] [Related]  

  • 25. [Changes in the condition for the use of Cavinton and Devincan. New regulation concerning the prescription and use of these 2 drugs].
    Orv Hetil; 1980 Jun; 121(25):1525-6. PubMed ID: 7454263
    [No Abstract]   [Full Text] [Related]  

  • 26. Cerebral metabolic, hemodynamic and antihypoxic properties of l-eburnamonine.
    Linée P; Lacroix P; Le Polles JB; Aurousseau M; Boulu R; Van den Driessche J; Albert O
    Eur Neurol; 1978; 17 Suppl 1():113-20. PubMed ID: 753626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
    Barzaghi F; Dragonetti M; Formento ML; Gueniau C; Nencioni A; Mantegazza P
    Arzneimittelforschung; 1986 Oct; 36(10):1442-8. PubMed ID: 3814205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of vincamine on platelet respiration].
    Pesce E; Viganò V; Piacenza G
    Farmaco Prat; 1978 Aug; 33(8):343-50. PubMed ID: 748059
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of L-eburnamonine on bronchial respiratory resistance in the anesthetized guinea pig. Comparison with vincamine].
    Linée P; Lacroix P; Laville MP; Le Pollès JB
    C R Seances Soc Biol Fil; 1978; 172(6):1208-13. PubMed ID: 159107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulatory effect of several cerebral circulatory drugs in man, with special reference to aminophylline, papaverine, cyclandelate, vincamine, prostaglandin E1 and isoxsuprine.
    Miyazaki M
    Jpn Circ J; 1978 Apr; 42(4):433-40. PubMed ID: 702768
    [No Abstract]   [Full Text] [Related]  

  • 31. [Interaction of vincamine on various effects of amphetamine at the central level].
    Sardi B; Pesce E; Piacenza G
    Farmaco Prat; 1978 Aug; 33(8):351-7. PubMed ID: 748060
    [No Abstract]   [Full Text] [Related]  

  • 32. Cerebral antioedematous effect of Teproside and of some vincamine derivatives.
    Borzeix MG; Cahn J
    Int J Clin Pharmacol Res; 1984; 4(4):259-61. PubMed ID: 6500773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vincamine TPS activity on glycoconjugate metabolism of the brain: effect on lysosomal enzymes.
    Federico A; D'Amore I
    Int J Clin Pharmacol Res; 1984; 4(4):277-9. PubMed ID: 6500774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vincamine in cerebral arteriosclerosis: therapeutic effects evaluated clinically and by retinal fluoro-angiography].
    Ardito R
    Clin Ter; 1979 Mar; 88(5):461-12. PubMed ID: 466968
    [No Abstract]   [Full Text] [Related]  

  • 35. [In vitro dissolution test: evaluation criterion for prolonged release dosage forms vincamine example (author's transl)].
    Buri P; Doelker E; Boucherat J
    Schweiz Rundsch Med Prax; 1981 Jul; 70(29):1310-3. PubMed ID: 7279852
    [No Abstract]   [Full Text] [Related]  

  • 36. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
    Imamoto T; Tanabe M; Shimamoto N; Kawazoe K; Hirata M
    Arzneimittelforschung; 1984; 34(2):161-9. PubMed ID: 6539108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General and cerebral haemodynamic activity of ethyl apovincaminate.
    Kárpáti E; Szporny L
    Arzneimittelforschung; 1976; 26(10a):1908-12. PubMed ID: 1037212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of vincamine and a vincamine-papaverine combination on erythrocyte flexibility in diabetic patients].
    Petruzzi E; Bucalossi A
    Minerva Cardioangiol; 1985 Nov; 33(11):671-3. PubMed ID: 4088469
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of vincamine on some enzymatic activities from various areas of the beagle dog cerebral cortex.
    Benzi G; Arrigoni E; Pastoris O; Marzatico F; Curti D; Piacenza G; Villa RF
    Farmaco Sci; 1981 Sep; 36(9):811-6. PubMed ID: 7297673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of vincamine on EEG sleep patterns in man: a pilot study.
    Albizzati MG; Bassi S; Binda G; Passerini D
    Curr Med Res Opin; 1980; 6(10):653-7. PubMed ID: 7428402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.